Late breaking Clinical Trials Abstract
 
 
     
  Abstract Submission

 

Abstract Submission is closed

-------------------------------------------------------------------------------------------------------------------

You are invited to submit abstracts for presentation at ISTH 2007. Abstracts should be submitted online only using the electronic abstract form on the website. Please read the important information below before proceeding to the online submission form. Please note that no proof reading will be done.

List of Topics

Rules
Abstracts must be submitted via this website www.isth2007.com.
Abstracts submitted by Email or fax will not be accepted.

 Go to www.isth2007.com on the Internet. Click on ‘’Abstract Submission’’ and follow instructions as given. CLOSED
 Fill out carefully all the fields of the abstract form (detailed information is provided to help you submit your abstract).
 The electronic submission system will be available from 20 October 2006 and will close on 2 February 2007, Midnight CET.
1. Please read carefully all instructions available on the internet abstract submission system before preparing your abstract. If you have successfully submitted your abstract, you will receive a confirmation number. If no confirmation number is received, the abstract has not been submitted correctly.
2. Failure to observe these guidelines may result in disqualification.
3. The internet abstract submission system works best with Netscape Navigator version 7+ or Microsoft Internet Explorer version 6+.
4. A paper should not be submitted to the XXIst ISTH Congress if it has been already presented internationally.
5. A paper cannot be accepted if the conflict of interest disclosure as not been filled out. On the on-line abstract form, tick the box and enter your initials.
6. Available space must be used as follows and contain the following sections: Introduction; Methods; Results; Conclusions.

One table can be included, but the total number of cells (columns+rows) may not exceed 16. Please note that tables may significantly reduce the number of available characters. The abstract cannot contain more than 2000 characters (blank spaces, punctuation as well as authors’ affiliation and titles included).

General Remarks
1. The presenting author of the abstract selected for presentation must be registered at the Congress.
2. Abstracts must contain data and meet international ethical standards.
3. Abbreviations should be defined.
4. The Introduction section should contain 1-2 sentences that clearly indicate the scientific question of the study and its clinical (or other) importance.
5. The Methods section should contain sufficient information to be able to understand the experimental design, the analytical techniques and the statistics used in the study.
6. The Results section should contain objective data to answer the scientific question.
7. The Conclusions section should provide only conclusions of the study directly supported by the results, along with implications for clinical practice, avoiding speculation and over generalization.
8. Trade names cannot be mentioned in the title. However, trade names in brackets will be accepted in the body of the text.
9. Please insure your abstract does not contain spelling, grammar or scientific mistakes, as it will be reproduced exactly as submitted. Linguistic accuracy is your responsibility.
10. The reviewers will judge the abstracts according to the relevance to ISTH, standard of English, objectivity of statements, description of what was done, suitability of methods to aims, conclusions confirmed by objective results, ethics, scientific value, potential clinical value, originality of work, and overall impression.
11. Authors will be notified by 30 March 2007 whether their abstract has been accepted, and they will be informed at the same time about the date, time and form of their presentation.
12. The name, address, telephone, fax number and Email address of the corresponding author should be given as indicated. The presenting author and the contact author must be the same person.
13. You can re-edit and modify your submitted abstract until the deadline by using the Returning-User Function.

Abstract Publication
All abstracts accepted for presentation will be published on the Congress Abstract CD-ROM. Abstracts will also be available for viewing on the Congress website. A CD-Rom containing PDFs of accepted posters will also be produced. Authors will be invited to submit a PDF of their actual poster for inclusion on this CD.

Presentation of Abstracts
 Abstracts can be accepted either as a poster, or an oral communication
 If your abstract is accepted as a poster you will be requested to be available for discussion during the corresponding poster viewing session.
 The usable surface of the display panels measures 150 cm (height) x 98 cm (width) [59 inches (height) x 39 inches (width)]. Pins and adhesive material will be provided.
 Please use letters large enough to be read from a distance of 1.5 meters (4.9 feet).
 Poster presenting authors will be asked to stand by their poster during scheduled poster presentation times.
 Oral presentations will be allocated 10 minutes each plus 5 minutes discussion time. Facilities to convert slides to data will be available at the Congress, if required. PowerPoint data projection with single screens will be available in all session rooms.
 Full details will be included in the acceptance letter.

Conflict of Interest Disclosure
If the research was supported by a pharmaceutical company you must indicate the company’s role in analysing the data or preparing the abstract.

Problems submitting?
If you experience any kind of problem or if you have questions, please do not hesitate to contact:
Lara Poethig
Phone: +41 22 33 99 629
Fax: +41 22 33 99 601
Email: lara.poethig@mci-group.com